The president and CEO of Physician Ancillary Management, Chris Manfuso has worked in the healthcare sector over the last two decades. He also serves as the national director of sales for Nubratori RX and Enovachem Pharmaceuticals, two well-known pharmaceutical firms. Chris Manfuso is in charge of the former company’s distribution network and products, such as Neuraptine (topical gabapentin) and Frotek (topical ketoprofen).
Ketoprofen gel is a topical (applied-on-skin) version of ketoprofen’s nonsteroidal anti-inflammatory drug. Doctors primarily prescribe topical ketoprofen for pain relief to patients, although some people use topical ketoprofen over the counter. The kinds of pain treatable with the gel include those caused by inflammation of tissues, such as backaches, arthritis, strains, and joint/muscle sprains.
When applied to the skin, topical ketoprofen initiates a biochemical reaction in the underlying muscles and other tissues where inflammation is present. The biochemical response discourages the tissue from synthesizing chemicals that are germane to the anti-inflammatory response and associated pain signals. When this happens, immediate relief is noticed.
Topical ketoprofen is a local anesthetic. This means its action is restricted to the part of the body where it is applied. This is advantageous since the risk of overdose is low compared to oral versions of the drug.
Chris Manfuso 